Published in Virology on October 01, 1973
Friend strain of spleen focus-forming virus: a recombinant between mouse type C ecotropic viral sequences and sequences related to xenotropic virus. J Virol (1977) 3.70
Effect of Fv-1 gene product on synthesis of linear and supercoiled viral DNA in cells infected with murine leukemia virus. J Virol (1980) 3.54
Host genetic control of recovery from Friend leukemia virus-induced splenomegaly: mapping of a gene within the major histocompatability complex. J Exp Med (1974) 2.89
Envelope gene sequences which encode the gp52 protein of spleen focus-forming virus are required for the induction of erythroid cell proliferation. J Virol (1982) 2.39
Induction of GIX antigen and gross cell surface antigen after infection by ecotropic and xenotropic murine leukemia viruses in vitro. J Virol (1976) 2.11
Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex. Proc Natl Acad Sci U S A (1979) 1.95
Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity. J Exp Med (1976) 1.90
Envelope gene of the Friend spleen focus-forming virus: deletion and insertions in 3' gp70/p15E-encoding region have resulted in unique features in the primary structure of its protein product. Proc Natl Acad Sci U S A (1983) 1.87
Biological activity of the spleen focus-forming virus is encoded by a molecularly cloned subgenomic fragment of spleen focus-forming virus DNA. Proc Natl Acad Sci U S A (1981) 1.86
Abelson virus-induced lymphomagenesis in mice. J Exp Med (1978) 1.81
Three laboratory strains of spleen focus-forming virus: comparison of their genomes and translational products. J Virol (1980) 1.60
Induction of endogenous and of spleen focus-forming viruses during dimethylsulfoxide-induced differentiation of mouse erythroleukemia cells transformed by spleen focus-forming virus. Proc Natl Acad Sci U S A (1975) 1.55
Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice. J Virol (1992) 1.55
Structural markers on core protein p30 of murine leukemia virus: functional correlation with Fv-1 tropism. Proc Natl Acad Sci U S A (1978) 1.51
Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus. J Virol (2007) 1.50
PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing. PLoS Pathog (2015) 1.49
Antibody-induced modulation of Friend virus cell surface antigens decreases virus production by persistent erythroleukemia cells: influence of the Rfv-3 gene. Proc Natl Acad Sci U S A (1979) 1.38
Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness. Proc Natl Acad Sci U S A (1995) 1.33
Abelson antigen: a viral tumor antigen that is also a differentiation antigen of BALB/c mice. Proc Natl Acad Sci U S A (1978) 1.32
Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points. Proc Natl Acad Sci U S A (2011) 1.26
CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection. J Virol (2005) 1.26
In vitro construction of a B-tropic virus by recombination: B-tropism is a cryptic phenotype of xenotropic murine retroviruses. Proc Natl Acad Sci U S A (1980) 1.25
Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication. J Immunol (2011) 1.23
CD4(+) T cells and gamma interferon in the long-term control of persistent friend retrovirus infection. J Virol (2001) 1.22
Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection. Proc Natl Acad Sci U S A (2004) 1.20
Analysis of translational products of Friend strain of spleen focus-forming virus. J Virol (1978) 1.19
Persistence of infectious Friend virus in spleens of mice after spontaneous recovery from virus-induced erythroleukemia. J Virol (1979) 1.13
Combining regulatory T cell depletion and inhibitory receptor blockade improves reactivation of exhausted virus-specific CD8+ T cells and efficiently reduces chronic retroviral loads. PLoS Pathog (2013) 1.08
Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. PLoS Pathog (2011) 1.05
Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1. Proc Natl Acad Sci U S A (2011) 1.04
Friend erythroleukemia antigen. A viral antigen specified by spleen focus-forming virus and differentiation antigen controlled by the Fv-2 locus. J Exp Med (1979) 1.03
Host restriction of Friend leukemia virus: gag proteins of host range variants. Proc Natl Acad Sci U S A (1981) 1.02
Temporal effects of gamma interferon deficiency on the course of Friend retrovirus infection in mice. J Virol (2002) 1.01
Molecular cloning of biologically active proviral DNA of the anemia-inducing strain of spleen focus-forming virus. J Virol (1982) 1.00
Reduction of retrovirus-induced immunosuppression by in vivo modulation of T cells during acute infection. J Virol (2004) 0.99
The detection of a spleen focus-forming virus neoantigen by lymphocyte-mediated cytolysis. J Exp Med (1978) 0.98
Fluidity of a retrovirus genome. J Virol (1984) 0.95
IFN-α treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3. J Immunol (2013) 0.90
Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo. Virology (2014) 0.80
Cas spleen focus-forming virus. II. Further biological and biochemical characterization. J Virol (1983) 0.78
Spontaneous regression of Friend virus-induced erythroleukemia. I. The role of the helper murine leukemia virus component. J Exp Med (1977) 0.77
Filariae-Retrovirus Co-infection in Mice is Associated with Suppressed Virus-Specific IgG Immune Response and Higher Viral Loads. PLoS Negl Trop Dis (2016) 0.75
Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection. J Virol (2017) 0.75
Fv-2: identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice. J Natl Cancer Inst (1970) 6.08
A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus. J Exp Med (1971) 5.50
FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci U S A (1991) 4.29
Susceptibility to two strains of Friend leukemia virus in mice. Science (1967) 4.12
Transmissible Agent Associated with 26 Types of Experimental Mouse Neoplasms. Science (1960) 3.50
Correlation of early murine leukemia virus titer and H-2 type with spontaneous leukemia in mice of the BALB/c times AKR cross: a genetic analysis. J Exp Med (1975) 2.98
Isolation and characterization of a lymphatic leukemia virus in the Friend virus complex. J Natl Cancer Inst (1971) 2.94
Editorial: Spleen focus-forming virus in Friend and Rauscher leukemia virus preparations. J Natl Cancer Inst (1975) 2.83
The effect of histocompatibility-2 type on response to friend leukemia virus in mice. J Exp Med (1968) 2.57
The histocompatibility-2 locus and susceptibility to tumor induction. Natl Cancer Inst Monogr (1966) 2.48
The inheritance of susceptibility to the Gross leukemia virus in mice. Genetics (1966) 2.38
Host control of endogenous murine leukemia virus gene expression: concentrations of viral proteins in high and low leukemia mouse strains. Proc Natl Acad Sci U S A (1974) 2.28
T-lymphocytes response to Friend virus-induced tumour cell lines in mice of strains congenic at H--2. Nature (1976) 1.99
Interactions between host and viral genomes in mouse leukemia. Annu Rev Genet (1977) 1.93
Selective incorporation of H-2 antigenic determinants into Friend virus particles. Nature (1977) 1.92
A classification of the murine leukemia viruses. Neutralization of pseudotypes of Friend spleen focus-forming virus by type-specific murine antisera. J Exp Med (1972) 1.92
Structural proteins of mammalian oncogenic RNA viruses: murine leukemia virus neutralization by antisera prepared against purified envelope glycoprotein. J Virol (1974) 1.87
The role of genetics in Gross virus leukemogenesis. Bibl Haematol (1970) 1.86
Independence of H-2K and H-2D antigenic determinants on the surface of mouse lymphocytes. J Exp Med (1973) 1.76
A major genetic locus affecting resistance to infection with murine leukemia viruses. 3. Assignment of the Fv-1 locus to linkage group 8 of the mouse. J Exp Med (1973) 1.68
Host-induced changes in infectivity of Friend spleen focus-forming virus. J Natl Cancer Inst (1970) 1.59
Properties of cell lines derived from tumors induced by Friend virus in BALB/c and BALB/c-H-2b mice. J Exp Med (1975) 1.55
Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities. J Exp Med (1986) 1.50
Evidence for an H-2/viral protein complex on the cell surface as the basis for the H-2 restriction of cytotoxicity. Nature (1977) 1.49
Spleen focus formation by polycythemic strains of Friend leukemia virus. Proc Soc Exp Biol Med (1968) 1.49
Nonrandom inclusion of H-2K and H-2D antigens in Friend virus particles from mice of various strains. J Exp Med (1978) 1.45
Acceleration by thymosin of the development of resistance to murine sarcoma virus-induced tumor in mice. Proc Natl Acad Sci U S A (1970) 1.38
Rapid assay of murine leukemia virus helper activity for Friend spleen focus-forming virus. J Natl Cancer Inst (1971) 1.37
Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene. Proc Natl Acad Sci U S A (1990) 1.33
Cellular antigen of Friend virus-induced leukemias. Cancer Res (1968) 1.33
Relation of chromosome 4 (linkage group 8) to murine leukemia virus-associated antigens of AKR mice. J Exp Med (1973) 1.27
Neutralization kinetics of friend and Rauscher leukemia viruses studied with the spleen focus assay method. Int J Cancer (1967) 1.26
FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens. J Exp Med (1989) 1.25
Fv-1 regulation of lymphoma development and of thymic ecotropic and xenotropic MuLV expression in mice of the AKR/J x RF/J cross. Cell (1978) 1.22
Antigens of murine leukemia viruses. Biochim Biophys Acta (1974) 1.19
The genetic basis of susceptibility to leukemia induction in mice by 3-methylcholanthrene applied percutaneously. J Exp Med (1978) 1.14
Viral protein expression in producer and nonproducer clones of friend erythroleukemia cell lines. J Virol (1981) 1.12
Maternally transmitted resistance to lymphoma development in mice of reciprocal crosses of the RF/J and AKR/J strains. Cell (1980) 1.11
Mutant Sl alleles of mice affect susceptibility to Friend spleen focus-forming virus. Science (1968) 1.10
Mechanisms of the H-2 effect on viral leukemogenesis. Scand J Immunol (1977) 1.09
Virus-induced polycythemia in mice: erythropoiesis without erythropoietin. Proc Soc Exp Biol Med (1968) 1.08
Genetic control by the W locus of susceptibility to (Friend) spleen focus-forming virus. Nature (1968) 1.08
Immunocompetent cell functions in mice infected with Friend leukemia virus. J Natl Cancer Inst (1970) 1.07
Enhancement of spleen focus formation and virus replication in Friend virus-infected mice. Cancer Res (1969) 1.07
Genetic control of the expression of murine leukemia virus proteins in tissues of normal, young adult mice. Cold Spring Harb Symp Quant Biol (1975) 1.07
Identification of an epitope encoded in the env gene of Friend murine leukemia virus recognized by anti-Friend virus cytotoxic T lymphocytes. Virology (1991) 1.04
Cell surface antigen induced by Friend murine leukemia virus is also in the virion. J Virol (1974) 1.03
Suppression of spontaneous lymphoma by previously undiscovered dominant genes in crosses of high- and low-incidence mouse strains. Virology (1982) 1.02
Genetic control of the antibody response to the H-2.2 alloantigen in mice. Transplant Proc (1973) 1.02
Genetic regulation of the antibody response to H-2Db alloantigens in mice. I. Differences in activation of helper T cells in C57BL/10 and BALB/c congenic strains. J Exp Med (1975) 0.99
Mouse leukemia: a model of a multiple-gene disease. J Natl Cancer Inst (1972) 0.99
Studies on the FMR antigen. Transplant Proc (1969) 0.99
Genetic and nongenetic factors in expression of infectious murine leukemia viruses in mice of the DBA/2 x RF cross. Cell (1980) 0.98
Tumors induced by murine sarcoma virus contain precursor cells capable of generating tumor-specific cytolytic T lymphocytes. J Exp Med (1979) 0.98
Variations in viral gene expression in Friend virus-transformed cell lines congenic with respect to the H-2 locus. Cell (1978) 0.97
Antigenic properties of cultured tumor cell lines derived from spleens of Friend virus-infected BALB/c and BALB/c-H-2b mice. J Exp Med (1975) 0.97
Temperature-dependent versus constant-rate blood perfusion modelling in ferromagnetic thermoseed hyperthermia: results with a model of the human prostate. Int J Hyperthermia (1994) 0.95
Interim report of the Presidential Commission on the Human Immunodeficiency Virus Epidemic: Chairman's recommendations--Part I. J Acquir Immune Defic Syndr (1988) 0.94
Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus. J Exp Med (1979) 0.94
Origin of spleen colonies generated by Friend virus-infected cells in mice. Cancer Res (1978) 0.93
Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment. Invest Ophthalmol Vis Sci (1998) 0.92
Characterization of a new intra-H-2 recombinant separation of the Ir-RE and Ir-GLT genes. J Exp Med (1974) 0.92
Suppression of H-2b-associated resistance to Friend erythroleukemia virus by a class I gene from the H-2d major histocompatibility complex haplotype. Proc Natl Acad Sci U S A (1991) 0.92
Suppression of endogenous murine leukemia virus by maternal resistance factor. J Exp Med (1983) 0.91
Spleen foci and polycythemia in C57B1 mice infected with host-adapted Friend leukemia virus. Int J Cancer (1970) 0.90
Influence of histoincompatibility between mother and foetus on placental size in mice. Nature (1971) 0.90
Defective Friend spleen focus-forming virus: pseudotype neutralization by helper-specific antisera. Nat New Biol (1971) 0.90
Studies of cloned Friend erythroleukemia tumor cells. Modulation of the tumor-specific cytologic T lymphocyte response by infectious Friend virus production in vitro. J Exp Med (1980) 0.89
Hyperthermia and irradiation for locally recurrent previously irradiated breast cancer. Strahlenther Onkol (1991) 0.89
Reversal by thymosin of increased susceptibility of immunosuppressed mice to Moloney sarcoma virus. Transplant Proc (1971) 0.89
Comparison of endogenous murine leukemia virus proviral organization and RNA expression in 3-methylcholanthrene-induced and spontaneous thymic lymphomas in RF and AKR mice. J Virol (1985) 0.88
Expression of differentiation and murine leukemia virus antigens on cells of primary tumors and cell lines derived from chemically induced lymphomas of RF/J mice. Proc Natl Acad Sci U S A (1984) 0.87
Extra-renal production of erythropoietin in man. Acta Haematol (1968) 0.87
Genetically determined resistance to 3-methylcholanthrene-induced lymphoma is expressed at the level of bone marrow-derived cells. J Exp Med (1987) 0.87
A comparison of various types of patient instruction in the proper administration of metered inhalers. Drug Intell Clin Pharm (1982) 0.87
Expression of viral RNA in Friend virus-induced erythroleukemia cells. Cell (1980) 0.87
The Fv-2r resistance gene in mice: its effect on spleen colony formation by Friend virus-transformed cells. J Natl Cancer Inst (1976) 0.87
Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations. Int J Radiat Oncol Biol Phys (1990) 0.86
Retroperitoneal paragangliomas: natural history and review of the literature. Wis Med J (1995) 0.86
Aggressive combined modality therapy for advanced local-regional breast carcinoma. J Clin Oncol (1984) 0.86
Construction of a D2.B6-Fv-2r congenic mouse strain: nonlethality of the homozygous Fv-2' genotype. J Natl Cancer Inst (1981) 0.85
Differential sensitivity of AKR murine leukemia and normal bone marrow cells to hyperthermia. Cancer Res (1983) 0.85
Approach to a retrovirus vaccine: immunization of mice against Friend virus disease with a replication-defective Friend murine leukemia virus. Proc Natl Acad Sci U S A (1992) 0.85
Genetically dominant resistance in mice to 3-methylcholanthrene-induced lymphoma. Proc Natl Acad Sci U S A (1980) 0.85
Ferromagnetic hyperthermia and iodine 125 brachytherapy in the treatment of choroidal melanoma in a rabbit model. Arch Ophthalmol (1989) 0.83
Fv-2r-mediated resistance of mouse bone-marrow cells to Friend spleen focus-forming virus infecton. Int J Cancer (1980) 0.83
Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes. J Exp Med (1981) 0.83
Combined neoplastic effects of vaccinia virus and 3-methylcholanthrene. II. Genetic factors. J Natl Cancer Inst (1972) 0.82
Helper activity of human leukemic tissue extracts for leukemia virus expression in mice. Proc Natl Acad Sci U S A (1971) 0.82
Genetic regulation of the antibody response to H-2Db alloantigens in mice. II. Tolerance to non-H-2 determinants abolishes the antibody response to H-2Db in B10.A(5R) mice. J Exp Med (1976) 0.82
Genetic factors in susceptibility to viral leukemogenesis. Prog Med Virol (1985) 0.82
Combined neoplastic effects of vaccinia virus and 3-methylcholanthrene. 3. Susceptibility and resistance in transplanted mouse skin. J Natl Cancer Inst (1973) 0.81
Infection and transformation of Fv-2rr erythroprogenitor cells with Friend virus. Virus Res (1987) 0.81
The influence of genetic background on the susceptibility of inbred mice to streptozotocin-induced diabetes. Diabetes (1984) 0.80
Use of hybridoma-resident variant cell lines to study H-2Db/FMR-specific cytotoxic T cells. Immunogenetics (1981) 0.80
Anti-Friend virus antibody-induced resistance of Friend virus-infected spleen cells to lysis mediated by anti-H-2 antisera. Cancer Res (1978) 0.80
Genetic regulation of the antibody response to H-2Db alloantigens in mice. III. Inhibition of the IgG Response to noncongenic cells by preimmunization with congenic cells. J Exp Med (1976) 0.80